Amdocs (DOX) is back in the spotlight after issuing softer full year 2026 guidance, pairing it with a planned CEO transition and fresh customer and product updates that leave investors weighing execution risk more carefully.

The recent guidance cut and CEO succession announcement have been accompanied by weaker momentum, with a 7 day share price return of 10.5% and a 90 day share price return of 14.21%. This has contributed to a 1 year total shareholder return of 12.57% and a 3 year total shareholder return of 18.32%, even after buybacks and dividend increases.

If this mix of telecom software, AI themes, and execution risk has your attention, you may want to see what else is out there via our screener of 33 AI infrastructure stocks.

So with Amdocs trading at US$73.34, sitting at a 30% discount to the average analyst price target and an estimated 47% intrinsic discount, is this recent pullback a chance to enter the stock, or is the market already accounting for future growth?

Most Popular Narrative: 23.2% Undervalued

At a last close of $73.34 versus a narrative fair value of $95.50, Amdocs is framed as materially undervalued while still facing measured growth expectations and tightening FY26 guidance.

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services. This is expanding its total addressable market and supporting sustained topline revenue growth.

Curious what kind of revenue trends, margin shifts, and future earnings multiple need to line up for that fair value to hold up? The narrative walks through a detailed set of forecasts and required assumptions that connect FY26 guidance, longer term earnings targets, and the discount rate into one cohesive valuation story.

Result: Fair Value of $95.50 (UNDERVALUED)

However, slower than expected scaling in cloud and GenAI services, combined with Amdocs reliance on a small group of major telecom clients, could put pressure on this thesis.

Build Your Own Amdocs Narrative

If you look at this and think the assumptions do not quite fit your view, you can test the data yourself, adjust the story, and Do it your way in just a few minutes.

A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Amdocs.

Looking for more investment ideas?

If Amdocs has you thinking more broadly about where to put your money to work, do not stop here. Widen your search now and keep your options open.

• Target strong value potential by scanning companies trading below what their fundamentals suggest using our list of 52 high quality undervalued stocks.
• Prioritize resilience by focusing on businesses with healthy balance sheets and cash positions through our solid balance sheet and fundamentals stocks screener (45 results).
• Hunt for lesser known opportunities with solid fundamentals using our screener containing 24 high quality undiscovered gems before everyone else starts paying attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.